<DOC>
	<DOCNO>NCT00262340</DOCNO>
	<brief_summary>The purpose study determine whether use non-invasive measurement airway inflammation improve clinical decision make child severe asthma compare conventional management ( British Thoracic Society Guidelines )</brief_summary>
	<brief_title>The Use Inflammatory Markers Guide Therapy Children With Severe Asthma</brief_title>
	<detailed_description>Children severe asthma pose management dilemma ; difficult reduce treatment symptomatic , plateau dose response curve inhale corticosteroid ( ICS ) may reach . Studies symptomatic adult asymptomatic child asthma suggest measuring induced sputum eosinophils allow well asthma management . We recruit 80 child severe asthma ( treat least 500 mcg/day inhale fluticasone equivalent ) . We see every three month year , perform sputum induction measurement exhale nitric oxide ( eNO ) . Half randomise conventional management ; half reduction ICS sputum eosinophil , ( sample produce ) eNO normal . The trial endpoint whether significant reduction median dose ICS inflammatory marker group , increase total number asthma exacerbation . This study also hypothesis generate . We use panel marker ( ) try improve clinical monitoring ; ( b ) determine molecular mechanism relapse severe asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Children &gt; 8 year severe asthma define : Taking least 500mcg fluticasone propionate ( equivalent ) per day , plus long acting beta agonist plus leukotriene antagonist previous trial Children take steroid sparing agent ( cyclosporin , azathioprine , methotrexate ) Children major respiratory diagnosis bronchiectasis</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Airway</keyword>
	<keyword>Inflammation</keyword>
</DOC>